Analysis results of prognostic factors affecting survival outcome for locoregional recurrence in postmastectomy of breast cancer

Zhiqiang Zhang, Sha Shi, Lili Liu, Tong Wu, Xiaoqi Li, Jing Shi, Lingyun Zhang, Lijie He
{"title":"Analysis results of prognostic factors affecting survival outcome for locoregional recurrence in postmastectomy of breast cancer","authors":"Zhiqiang Zhang, Sha Shi, Lili Liu, Tong Wu, Xiaoqi Li, Jing Shi, Lingyun Zhang, Lijie He","doi":"10.3760/CMA.J.ISSN.1673-8799.2017.03.006","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the prognostic factors affecting survival outcome for locoregional recurrence in postmastectomy of breast cancer. \n \n \nMethods \nA retrospective study was performed on 61 breast cancer patients who suffering outcome of locoregional recurrence(LRR)treated by modified radical mastectomy.The clinical data of LRR patients with breast cancer and distant metastasis and clinical pathologic factors of survival were analyzed. \n \n \nResults \nUnivariate analysis showed that triple-negative breast cancer, HER2-enriched breast cancer, time to LRR less than 2 years, no surgical removal of the lesions of LRR were correlated to survival outcome for LRR in postmastectomy of breast cancer.Multivariate analysis revealed that triple-negative breast cancer, HER2-enriched breast cancer, no surgical removal of the lesions of LRR were independent risk factors influencing risk of distant metastasis for LRR in postmastectomy of breast cancer.Among them, the risks of distant metastasis of triple-negative breast cancer, HER2-enriched breast cancer after LRR are 3.58 times and 2.87 times more than Luminal A/B(HER2-negative)breast cancer.In addition, triple-negative breast cancer, HER2-enriched breast cancer were independent risk factors influencing overall survival after LRR, their risk of death were 3.886 times and 3.097 times more than Luminal A/B(HER2-negative)breast cancer. \n \n \nConclusion \nLRR of breast cancer after mastectomy correlates with a high risk of distant metastasis events and death in particular in patients with triple-negative and HER2-enriched breast cancer.Radiotherapy and mastectomy for LRR are warranted to reduce the risk of distant metastasis. \n \n \nKey words: \nTriple-negative breast cancer; HER2-enriched breast cancer; Locoregional recurrence; Modified radical mastectomy; Breast cancer","PeriodicalId":64135,"journal":{"name":"中国临床实用医学","volume":"8 1","pages":"26-33"},"PeriodicalIF":0.0000,"publicationDate":"2017-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国临床实用医学","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-8799.2017.03.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To investigate the prognostic factors affecting survival outcome for locoregional recurrence in postmastectomy of breast cancer. Methods A retrospective study was performed on 61 breast cancer patients who suffering outcome of locoregional recurrence(LRR)treated by modified radical mastectomy.The clinical data of LRR patients with breast cancer and distant metastasis and clinical pathologic factors of survival were analyzed. Results Univariate analysis showed that triple-negative breast cancer, HER2-enriched breast cancer, time to LRR less than 2 years, no surgical removal of the lesions of LRR were correlated to survival outcome for LRR in postmastectomy of breast cancer.Multivariate analysis revealed that triple-negative breast cancer, HER2-enriched breast cancer, no surgical removal of the lesions of LRR were independent risk factors influencing risk of distant metastasis for LRR in postmastectomy of breast cancer.Among them, the risks of distant metastasis of triple-negative breast cancer, HER2-enriched breast cancer after LRR are 3.58 times and 2.87 times more than Luminal A/B(HER2-negative)breast cancer.In addition, triple-negative breast cancer, HER2-enriched breast cancer were independent risk factors influencing overall survival after LRR, their risk of death were 3.886 times and 3.097 times more than Luminal A/B(HER2-negative)breast cancer. Conclusion LRR of breast cancer after mastectomy correlates with a high risk of distant metastasis events and death in particular in patients with triple-negative and HER2-enriched breast cancer.Radiotherapy and mastectomy for LRR are warranted to reduce the risk of distant metastasis. Key words: Triple-negative breast cancer; HER2-enriched breast cancer; Locoregional recurrence; Modified radical mastectomy; Breast cancer
影响乳腺癌切除术后局部复发患者生存结果的预后因素分析
目的探讨影响癌症术后局部复发患者生存率的预后因素。方法对61例经改良根治性乳房切除术后局部复发(LRR)的癌症患者进行回顾性研究。分析了癌症和远处转移的LRR患者的临床资料和临床病理生存因素。结果单因素分析显示,癌症三阴性乳腺癌、HER2-富集型癌症乳腺癌、LRR时间小于2年、未手术切除LRR病灶与乳腺癌术后LRR的生存结果相关。多因素分析显示,癌症三阴性乳腺癌、HER2-富集型癌症乳腺癌、未手术切除LRR病灶是影响癌症术后LRR远处转移风险的独立危险因素。其中,三阴性癌症、HER2阴性癌症LRR后发生远处转移的风险分别是Luminal A/B(HER2阴性)癌症的3.58倍和2.87倍。此外,三阴性乳腺癌癌症、HER2-富集的癌症是影响LRR后总生存率的独立危险因素,其死亡风险分别是Luminal A/B(HER2-阴性)癌症的3.886倍和3.097倍。结论癌症乳房切除术后LRR与远处转移事件和死亡的高风险相关,尤其是在三阴性和HER2富集的癌症患者中。LRR的放射治疗和乳房切除术有助于降低远处转移的风险。关键词:癌症三阴性;HER2-富集型乳腺癌症;局部复发;改良根治性乳房切除术;癌症乳腺
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
6167
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信